ALGS
Price
$7.22
Change
-$0.41 (-5.37%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
46.66M
STRO
Price
$0.80
Change
-$0.01 (-1.23%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
68.02M
42 days until earnings call
Interact to see
Advertisement

ALGS vs STRO

Header iconALGS vs STRO Comparison
Open Charts ALGS vs STROBanner chart's image
Aligos Therapeutics
Price$7.22
Change-$0.41 (-5.37%)
Volume$5.37K
Capitalization46.66M
Sutro Biopharma
Price$0.80
Change-$0.01 (-1.23%)
Volume$50.73K
Capitalization68.02M
ALGS vs STRO Comparison Chart in %
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. STRO commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and STRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ALGS: $7.63 vs. STRO: $0.81)
Brand notoriety: ALGS and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 99% vs. STRO: 54%
Market capitalization -- ALGS: $46.66M vs. STRO: $68.02M
ALGS [@Biotechnology] is valued at $46.66M. STRO’s [@Biotechnology] market capitalization is $68.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALGS and STRO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while STRO’s TA Score has 3 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 4 bearish.
  • STRO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than STRO.

Price Growth

ALGS (@Biotechnology) experienced а -8.84% price change this week, while STRO (@Biotechnology) price change was +1.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +32.55%, and the average quarterly price growth was +15.13%.

Reported Earning Dates

ALGS is expected to report earnings on May 06, 2025.

STRO is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STRO($68M) has a higher market cap than ALGS($46.7M). STRO YTD gains are higher at: -56.234 vs. ALGS (-80.848). ALGS has higher annual earnings (EBITDA): -83.89M vs. STRO (-203.18M). STRO has more cash in the bank: 249M vs. ALGS (138M). ALGS has less debt than STRO: ALGS (7.87M) vs STRO (21.4M). STRO has higher revenues than ALGS: STRO (66.4M) vs ALGS (3.27M).
ALGSSTROALGS / STRO
Capitalization46.7M68M69%
EBITDA-83.89M-203.18M41%
Gain YTD-80.848-56.234144%
P/E RatioN/AN/A-
Revenue3.27M66.4M5%
Total Cash138M249M55%
Total Debt7.87M21.4M37%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSSTRO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KORE2.360.06
+2.57%
KORE Group Holdings
JPM284.062.80
+1.00%
JPMorgan Chase & Co
ARQT14.470.14
+0.98%
Arcutis Biotherapeutics
RMR16.48-0.03
-0.18%
RMR Group (The)
FCN161.67-0.79
-0.49%
FTI Consulting

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-7.40%
XNCR - ALGS
40%
Loosely correlated
+3.51%
STRO - ALGS
39%
Loosely correlated
-2.08%
RLAY - ALGS
38%
Loosely correlated
-1.51%
CRNX - ALGS
34%
Loosely correlated
-1.71%
ARWR - ALGS
33%
Loosely correlated
-1.88%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with ALGS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then ALGS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-2.08%
ALGS - STRO
44%
Loosely correlated
-7.40%
TCRX - STRO
40%
Loosely correlated
-8.33%
TRDA - STRO
40%
Loosely correlated
-0.28%
ATXS - STRO
40%
Loosely correlated
-1.91%
FATE - STRO
38%
Loosely correlated
-0.85%
More